Award
Delivery Order #SPE2DR26FL436
Delivery Order for Humalog Vials under Pharmaceutical IDIQ Contract
Buyer
Defense Logistics Agency
Award Amount
$231.00
Ceiling
$231.00
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FL436
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery/indefinite quantity (IDIQ) agreement with AmerisourceBergen Drug Corp, a prominent healthcare solutions provider specializing in pharmaceutical distribution. The specific procurement involves Humalog 100 Unit/mL Vial 10mL, an essential pharmaceutical product used in diabetes management. This delivery order supports the broader mission of ensuring continuous access to critical medications for healthcare agencies, contributing significantly to patient care and public health outcomes. The scope includes the timely delivery of the specified pharmaceutical product to the designated location in Conshohocken, Pennsylvania. The contract was awarded as part of a pre-established framework agreement, facilitating efficient and streamlined acquisitions. The performance period for this order is short-term, spanning a few days in early March 2026. The contract builds upon the parent IDIQ agreement awarded for pharmaceutical products, enabling long-term collaboration to enhance supply chain reliability and healthcare service delivery.
Description
4571063051!HUMALOG 100 UNIT/ML VIAL 10ML